Clinical Trials Directory

Trials / Unknown

UnknownNCT04952103

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.

Conditions

Interventions

TypeNameDescription
OTHERno interventionThe patient's treatment is determined by the physician in charge according to the patient's clinical situation and relevant guidelines, without additional intervention.

Timeline

Start date
2021-06-18
Primary completion
2023-06-18
Completion
2024-06-18
First posted
2021-07-07
Last updated
2021-07-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04952103. Inclusion in this directory is not an endorsement.

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China (NCT04952103) · Clinical Trials Directory